Recent

% | $
Quotes you view appear here for quick access.

GW Pharmaceuticals plc Message Board

  • flshtogo flshtogo Oct 14, 2013 2:00 PM Flag

    PUGE: U.S. #$%$ market will quadruple next five years.

    GWP decade ahead of competitors THC and cannaboid delivery method. $62 target is conservative.

    There is no US approved drug to treat PTSD. Cannoboid may be the cure.
    OTC: PUGE Cannabis BioTech is investigating alternatives such as topical applications and infusing active ingredients into foods and beverages, which will open up the benefits to a significantly larger segment of the population. The company is also exploring sophisticated transmucosal delivery systems (administered through the mucous membranes).

    According to a recent Pew Research report, for the first time in more than 40 years a majority of Americans favor legalization of marijuana use. The manner in which it is consumed is producing a fast-growing industry in alternative delivery methods. The Wall Street Journal reported the $1.7 billion U.S. #$%$ market will quadruple in size during the next five years.

    PROFIT: Projected cannabis sales are $3 billion in 2014 and $6 billion in 2016. In US 20 states plus the District of Columbia have legalized cannabis for medical reasons and the list of states will continue to grow.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
GWPH
114.11+0.21(+0.18%)Jul 30 4:00 PMEDT